Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome

Internal Medicine

Volumn 42, Issue 12, 2003, Pages 1240-1243

  Tokashiki, Takashi ^a   Hashiguchi, Teruto ^a   Arimura, Kimiyoshi ^a   Eiraku, Nobutaka ^a   Maruyama, Ikuro ^a   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Coagulation; Crow Fukase syndrome; Vascular endothelial growth factor; Vascular permeability factor; VPF

Indexed keywords

ANTITHROMBIN III; ARGATROBAN; DALTEPARIN; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; NAFAMSTAT MESILATE; PREDNISOLONE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); CROW FUKASE SYNDROME; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEG EDEMA; MALE; MULTIPLE ORGAN FAILURE; POLYNEUROPATHY; PREDICTION; SKIN DEFECT; SPLENOMEGALY; SYMPTOM; THROMBOCYTE COUNT;

EID: 1642422281     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.1240     Document Type: Article

References (17)

1. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 34: 712-720, 1984.
2. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
3. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702, 1996.
4. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 21: 1390-1397, 1998.
5. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 40: 786-787, 1997.
6. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 23: 1051-1056, 2000.
7. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 275: H1054-H1061, 1998.
8. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci Colch 94: 395-404, 1998.
9. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964, 1998.
10. Möhle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94: 663-668, 1997.
11. Saida K, Kawakami H, Ohta M, Iwamura K. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 20: 486-492, 1997.
12. Nakahara K, Hoketsu Y, Sano Y, Shinmyozu K, Igata A. Improvement of parameters concerning blood coagulation and complement systems in a case of Crow-Fukase syndrome. Rinsho Shinkeigaku (Clin Neurol) 25: 755-759, 1985 (in Japanese, Abstract in English).
13. Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine 75: 226-232, 1996.
14. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271: 17629-17634, 1996.
15. Bova G, Pasqui AL, Saletti M, Bruni F, Auteri A. POEMS syndrome with vascular lesions: a role for interleukin-1 beta and interleukin-6 in crease - a case report. Angiology 49: 937-940, 1998.
16. Sano H, Terano T, Nakumo K. Beneficial treatment of argatroban on polyneuropathy associated with Crow-Fukase syndrome. A case report. Shinkei Tiryogaku (Neurol Treat) 10: 121-125, 1993 (in Japanese, Abstract in English).
17. Niimi H, Arimura K, Jonosono M, et al. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Intern Med 39: 1101-1104, 2000.